|
STK24 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.308200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.874400E-01 |
| Normal-vs-Stage2 |
5.761000E-01 |
| Normal-vs-Stage3 |
3.823600E-01 |
| Normal-vs-Stage4 |
1.106800E-01 |
| Stage1-vs-Stage2 |
9.277000E-01 |
| Stage1-vs-Stage3 |
8.501400E-01 |
| Stage1-vs-Stage4 |
5.248800E-01 |
| Stage2-vs-Stage3 |
8.246400E-01 |
| Stage2-vs-Stage4 |
4.740400E-01 |
| Stage3-vs-Stage4 |
6.192200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.301600E-01 |
| Normal-vs-AfricanAmerican |
9.303800E-01 |
| Normal-vs-Asian |
9.628500E-02 |
| Caucasian-vs-AfricanAmerican |
2.613600E-01 |
| Caucasian-vs-Asian |
4.735400E-01 |
| AfricanAmerican-vs-Asian |
1.899370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.578800E-01 |
| Normal-vs-Female |
8.683600E-01 |
| Male-vs-Female |
2.785400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.925410E-01 |
| Normal-vs-Extreme_Weight |
1.762760E-01 |
| Normal-vs-Obese |
6.597400E-01 |
| Normal-vs-Extreme_Obese |
1.667750E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.141600E-01 |
| Normal_Weight-vs-Obese |
1.038770E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.910400E-01 |
| Extreme_Weight-vs-Obese |
9.083700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.884000E-01 |
| Obese-vs-Extreme_Obese |
4.267700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.210760E-01 |
| Normal-vs-Age(41-60Yrs) |
7.725800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.205000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.803600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.748620E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.187800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.725200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.458500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.635600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.513600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.618000E-01 |
| Normal-VS-Type2 PRCC |
1.577910E-02 |
| Normal-VS-KIRP CIMP |
2.741200E-01 |
| Normal-VS-Unclassified PRCC |
6.228800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.916900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.030600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.721600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.408200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.174000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.037000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.383520E-02 |
| Normal-vs-N1 |
2.753000E-01 |
| Normal-vs-N2 |
9.762700E-03 |
| N0-vs-N1 |
3.208800E-01 |
| N0-vs-N2 |
2.171400E-01 |
| N1-vs-N2 |
1.183770E-01 |
|
|
